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Lung cancer remains the most lethal form of cancer in men and has now surpassed breast cancer in women. It is responsible for 28% of all the cancer-related deaths [1]. In the developed 
countries, incidence and mortality from lung cancer in females is rising, 
whereas it is declining in males. The worldwide incidence is 14% 
whereas it constitutes 6.8% of all cancers in India [2]. In our country, 
it is responsible for 6% of total deaths, in males it accounts for 78.8 
deaths/lakh population and in females 71.8 deaths/lakh population. 
In addition to smoking, occupational exposure to carcinogens, indoor 
air pollution, and dietary factors have been included in causation of 
lung cancer. Primary lung cancers, which originate in the lungs, are 
divided into two main types; small cell lung cancer (SCLC) and 
non-small cell lung cancer (NSCLC). NSCLC, approximately 80% 
of lung cancer diagnoses. There are three types of NSCLC, namely, 
squamous cell carcinoma, adenocarcinoma and large cell carcinoma. 
Squamous cell carcinoma is still the commonest histological type in 
India in contrast to the Western countries although adenocarcinoma 
is becoming more common [3].
Various invasive and non-invasive investigations are available 
for evaluation of lung cancer, e.g., chest X-ray, computed 
tomography (CT) thorax, fine needle aspiration cytology (FNAC), 
bronchoscopy, positron emission tomography (PET) scan, and 
magnetic resonance imaging. Most of the patients have locally 
advanced or disseminated disease at presentation and are not 
candidates for surgery. Chemotherapy applied as an adjunct with 
radiation improves survival and the quality of life. New anticancer 
drugs, which have emerged during the last decade, have shown an 
improved efficacy-toxicity ratio.
This study is designed to evaluate the epidemiological, clinico-
pathological aspects of lung cancer.
Aims and Objectives
Primary
1. To study the clinico-radiological and pathological profile of 
lung cancer patients
2. Stage of presentation of lung cancer.
Secondary
1. To Measure yield of diagnostic modalities used in lung cancer
2. Histological differences of lung cancer between smoker and 
non-smoker patients.
ABSTRACT
Background: Lung cancer is one of the most common cancers and cause of cancer-related deaths worldwide. The clinico-
pathological profile of lung cancer has shown marked regional and geographical variation. Majority of the patients have locally 
advanced or disseminated disease at presentation and are not candidates for surgery. Objective: The aim of this study was to 
evaluate the clinico-radiological and pathological profile of lung cancer patients and difference in histopathology between 
smoker and non-smoker. We also assessed yield of the various diagnostic procedures used for confirmation of lung cancer. 
Materials and Methods: A total of 30 patients diagnosed between May 1, 2016, and December 31, 2016. The complete 
demographic profile, smoking status, clinical, radiological, and diagnostic details were recorded in the study. Data were entered 
and analyzed using SPSS software. Results: A total of 30 patients (19 male and 11 female) included in our study with mean age of 
55.26 years. Cough (80%) and dyspnea (80%) were the most common symptom and mass (86%), pleural effusion (53.3%) was the 
most common radiological presentation of patients. Clubbing and hemoptysis both was found only in 8 out of 30 (26%) patients. 
Adenocarcinoma (46.6%) was the most common histopathological type followed by squamous cell carcinoma (16.6%) and small 
cell carcinoma (13.3%). The majority of patients (60%) presented in Stage 4. Computed tomography guided biopsy had better yield 
in compare to ultrasonography guided (80% vs. 70.8%). Bronchoscopic procedure had lowest yield (38.8%). Conclusion: The 
clinicopathological profile of lung cancer has changed in last few years, especially in the increase in adenocarcinoma incidence, 
and now it is the most common cause in both smokers and non-smoker.
Key words: Adenocarcinoma, Lung cancer, Pleural effusion, Smoking
Rai et al. A clinico-radiological and pathological profile of Lung cancer patients
Vol 2 | Issue 1 | Jan - Mar 2017 Eastern J Medical Sciences 9
MATERIALS AND METHODS
This was a retrospective analysis of all the patients diagnosed 
with lung cancer in the Department of Pulmonary Medicine, All 
India Institute of Medical Sciences, Patna between May 1, 2016, 
and December 31, 2016. Complete demographic profile, smoking 
status, clinical, radiological and diagnostic details were recorded 
in the study. Staging was done according to the 6th edition of 
American Joint Committee on Cancer staging system based on the 
available clinical and radiological findings. Age cutoff (40 years) 
was accepted as the limit to differentiate younger from older 
patients. Diagnostic modalities were recorded, including fibrotic 
bronchoscopy and/or ultrasonography (USG), or CT guided 
tissue sampling from suspected pulmonary lesion, pleural fluid 
analysis and cytological examination of regional lymph nodes 
and metastatic deposits as appropriate. CT scan of the thorax was 
done in the majority of cases. CT scan of the abdomen, brain or 
other parts of the body, bone scan, and PET-CT scan were done as 
per clinical indication for diagnostic or staging purposes.
Definition [4]
•	 Non-smoker:	Person	who	had	never	smoked	or	had	smoked	





Only those cases with a confirmed histological or cytological 
diagnosis of primary bronchogenic carcinoma were included.
Exclusion Criteria
Patient with primary mediastinal mass, primary pleural mass. 
Lymphoproliferative disorder or patient already received 
treatment for lung cancer.
Statistical Analysis
All the data were entered and analyzed using SPSS software 
(SPSS Inc., Released 2009. PASW Statistics for Windows, 
Version 18.0, SPSS Inc., Chicago, IL, USA).
RESULTS
A total of 30 patients diagnosed with lung cancer in pulmonary 
medicine department between May and December 2016, which 
comprises 19 male and 11 female. There were 60% patients 
belonged to age between 40 and 60 years. The average age of 
study patients was 55.26 years. Out of 30 patients, 16 patients 
are smoker and most of them are bidi smoker (30%) (Table 1). 
When we look for clinical symptoms, cough (80%) and dyspnea 
(80%) were the most common symptom found followed by 
anorexia and hemoptysis (Table 2 and Figure 1). On examination, 
pleural effusion was the most common finding (40%). Clubbing 
was present in only 8 patients (26%). Radiological examination 
shows mass was most common finding (86%) followed by pleural 
effusion (Table 2). Most of the patients (60%) presented in very 
advanced stage (Table 3).
NSCLC was diagnosed in 26 (86.6%) patients while 4 
(13.3%) patients had SCLC. The most common histopathological 
type found was adenocarcinoma (46.6%) followed by 
squamous cell carcinoma (16.6%). Adenocarcinoma was most 
common histopathological type in non-smoker. In non-smoker, 
Figure 1: Prevalence of symptoms in lung cancer (number on Y axis 
represent number of study patients)
Figure 2: Distribution of histological type of lung cancer
Table 1: Basic characteristics of patients








Mean age (years) 55.26
Smoker 16 (53.33)
Bidi: cigarette: hukka 12:2:2 (75:12:12)
Mean duration of smoking (years) 13.69
Mean total duration of illness (month) 4.8
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adenocarcinoma and squamous cell carcinoma are equally 
prevalent (Table 4 and Figure 2). Among diagnostic modalities, 
CT guided biopsy had better yield in compare to USG guided 
sample (80% vs. 70%). Bronchoscopic procedure had lowest 
yield (38.8%) (Table 5).
DISCUSSION
In this study, the maximum incidence of lung cancer was found 
in the 40-60 years age group with mean age of 55.3 years similar 
to previous studies [1-4]. These studies show only 13.3% patients 
belong to age group <40 years. The male to female ratio was 
4.3:1, which is similar to other Indian studies [5,6]. The reports 
from Indian cancer registry a ratio varying from 2.6:1 to 7.0:1 in 
different regions [6]. Gupta et al. [7] in their study also reported 
a higher incidence in females <40 years old, with a ratio of 
male to female patients was 1.7:1. These studies show female 
predominance may be due to small sample size and also due 
to increased susceptibility to carcinogens. Among risk factors, 
smoking was the commonest risk factor in which bidi was used 
by most of the patients followed by cigarette and hukka [8-10]. In 
this study, smoker to the non-smoker ratio was found to be 1.7:1.0. 
In other studies [11], range of this ratio was varies from 1.9:1 to 
5.3:1. Adenocarcinoma was the most common histology found 
followed by squamous cell carcinoma and small cell carcinoma. 
Our finding supported by many Asian and western studies which 
show that adenocarcinoma was more common histological 
type than squamous cell carcinoma [12,13]. This shift might be 
attributable partly to the smoking habits, particularly filtered 
cigarettes; moreover, there is also increasing the incidence of 
lung cancer in females and non-smokers [14]. It was also shown 
that adenocarcinoma was the most common histology in both 
smoker and non-smoker. Older Indian studies [15] have described 
squamous cell carcinoma as the commonest histology, but some 
recent studies from two major centers are showing a changing 
pattern in India [16,17]. This study also shows that mass was 
the most common radiological presentation followed by pleural 
effusion which is similar to other studies [18]. Pleural effusion 
more common in our studies which may be due to more number 
of adenocarcinoma patients. The bronchoscopic procedure most 
commonly performed for centrally located tumor in compare to 
peripheral located tumor where CT or USG guided FNAC and 
biopsy selected. In the present studies, USG guided FNAC was 
performed more than bronchoscopy. This study shows highest 
yield by CT guided biopsy in compare to USG guided sample 
with no complication; other studies have similar finding [19]. The 
bronchoscopic procedure had lowest yield in these studies and 
this may be due to more number of peripheral located tumor.
CONCLUSION
The clinico-pathological profile of lung cancer has changed in 
last few years and especially in the increase in adenocarcinoma 
incidence, and now it is the most common cause in both smokers 
and non-smoker. The bronchoscopic procedure is the most 
common procedure performed for centrally located tumor in 
compare to peripheral located tumor. Imaging-guided FNAC 
procedure have been performed.
Table 2: Clinical-radiological presentation of study patients
Symptoms Total n=30 (%) Mean 
duration (month)
Cough 24 (dry in 8) (80.0) 2.4
Chest pain 14 (46.6) 1.0
Dyspnea 24 (80.0) 3.0
Hemoptysis 8 (26.6) 1.5
Weight loss 18 (60.0) -






SVC syndrome 4 (13.3)
Pleural effusion 12 (40)
Radiological 
presentation






SVC: Superior vena cava
Table 3: Stage-wise presentation of study patients
TNM stage Total n=30 (%)
Stage 1 0 (0)
Stage 2 0 (0)
Stage 3A 2 (0.06)
Stage 3B 10 (33.33)
Stage 4 18 (60)
TNM: Tumor node metastasis
Table 4: Histopathological distribution in smoker and non-smoker
Histological type Histopathological type Total 30 (100%) Smoker 16 (53.33%) Non-smoker 14 (46.66%)
NSCLC
26 (86.6%)
Adenocarcinoma 14 (46.6) 5 9
Squamous cell Ca 5 (16.6) 3 2
Poorly differentiated Ca 7 (23.3) 5 2
SCLC
4 (13.3%)
Small cell Ca 4 (13.3) 3 1
NSCLC: Non-small cell lung cancer, SCLC: Small cell lung cancer
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